JavaScript NENÍ povolen !

Prosím povolte JavaScript.

Článek

PubMed

Záznam pochází z PubMed

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

Sessa, C
Autor Sessa, C Medical Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland
Balmaña, J
Autor Balmaña, J Medical Oncology Hospital Vall d'Hebron and Hereditary Cancer Genetics Group, Vall d'Hebron Institut of Oncology, Barcelona, Spain
Bober, S L
Autor Bober, S L Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute/Harvard Medical School, Boston, USA
Cardoso, M J
Autor Cardoso, M J Champalimaud Foundation, Breast Unit and Faculdade de Medicina, Lisbon, Portugal
Colombo, N
Autor Colombo, N Department of Gynecologic Oncology, Istituto Europeo di Oncologia e IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Curigliano, G
Autor Curigliano, G Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy
Domchek, S M
Autor Domchek, S M Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
Evans, D G
Autor Evans, D G Manchester Centre for Genomic Medicine, Division of Evolution Infection and Genomic Sciences, University of Manchester, MAHSC, Manchester, UK; Manchester Centre for Genomic Medicine, MAHSC, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK
Fischerova, D
Autor Fischerova, D Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
Harbeck, N
Autor Harbeck, N Breast Center, Department of Obstetrics & Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany
Kuhl, C
Autor Kuhl, C Department of Diagnostic and Interventional Radiology, University Hospital Aachen, University Hospital Aachen (UKA), RWTH Aachen, Germany
Lemley, B
Autor Lemley, B KIU - Patient Organisation for Women with Gynaecological Cancer, Copenhagen, Denmark; Clinical Trials Project, ESGO ENGAGe, Prague, Czech Republic
Levy-Lahad, E
Autor Levy-Lahad, E Medical Genetics Institute, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
Lambertini, M
Autor Lambertini, M Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
Ledermann, J A
Autor Ledermann, J A Department of Oncology, UCL Cancer Institute, University College London and UCL Hospitals, London, UK
Loibl, S
Autor Loibl, S GBG Forschungs GmbH, Neu-Isenburg, Germany
Phillips, K-A
Autor Phillips, K-A Department of Medical Oncology, Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
Paluch-Shimon, S
Autor Paluch-Shimon, S Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel
ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Autor ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Annals of oncology. 2023 Jan ; 34 (1) : 33-47. [epub] 20221025

Ann Oncol
ISSN 1569-8041 | 0923-7534
Zdroj

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu směrnice pro lékařskou praxi, práce podpořená grantem, časopisecké články

Perzistentní odkaz https://www.medvik.cz/link/pmid36307055

PubMed 36307055
DOI 10.1016/j.annonc.2022.10.004
PII: S0923-7534(22)04193-X
Knihovny.cz E-zdroje

Klíčová slova
BRCA, ESMO Clinical Practice Guideline, hereditary breast and ovarian cancer syndromes, risk reduction,
MeSH
časná detekce nádoru MeSH
chování snižující riziko MeSH
dědičné nádorové syndromy * MeSH
genetická predispozice k nemoci MeSH
lidé MeSH
nádory prsu * diagnóza genetika prevence a kontrola MeSH
nádory vaječníků * diagnóza epidemiologie genetika MeSH
Check Tag
lidé MeSH
ženské pohlaví MeSH
Publikační typ
časopisecké články MeSH
práce podpořená grantem MeSH
směrnice pro lékařskou praxi MeSH

Basser Center for BRCA Abramson Cancer Center University of Pennsylvania Philadelphia USA

Breast Center Department of Obstetrics and Gynecology and Comprehensive Cancer Center Munich LMU University Hospital Munich Germany

Champalimaud Foundation Breast Unit and Faculdade de Medicina Lisbon Portugal

Department of Diagnostic and Interventional Radiology University Hospital Aachen University Hospital Aachen RWTH Aachen Germany

Department of Gynecologic Oncology Istituto Europeo di Oncologia e IRCCS Milan Italy; Department of Medicine and Surgery University of Milano Bicocca Milan Italy

Department of Internal Medicine and Medical Specialties School of Medicine University of Genova Genoa Italy; Department of Medical Oncology U O Clinica di Oncologia Medica IRCCS Ospedale Policlinico San Martino Genoa Italy

Department of Medical Oncology Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Australia

Department of Oncology UCL Cancer Institute University College London and UCL Hospitals London UK

Department of Psychosocial Oncology and Palliative Care Dana Farber Cancer Institute Harvard Medical School Boston USA

Early Drug Development for Innovative Therapies Division Istituto Europeo di Oncologia IRCCS Milan Italy; Department of Oncology and Hemato Oncology University of Milano Milan Italy

GBG Forschungs GmbH Neu Isenburg Germany

Gynecologic Oncology Center Department of Obstetrics and Gynecology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

KIU Patient Organisation for Women with Gynaecological Cancer Copenhagen Denmark; Clinical Trials Project ESGO ENGAGe Prague Czech Republic

Manchester Centre for Genomic Medicine Division of Evolution Infection and Genomic Sciences University of Manchester MAHSC Manchester UK; Manchester Centre for Genomic Medicine MAHSC St Mary's Hospital Manchester University Hospitals NHS Foundation Trust Manchester UK

Medical Genetics Institute Shaare Zedek Medical Center Faculty of Medicine The Hebrew University of Jerusalem Jerusalem Israel

Medical Oncology Hospital Vall d'Hebron and Hereditary Cancer Genetics Group Vall d'Hebron Institut of Oncology Barcelona Spain

Medical Oncology Oncology Institute of Southern Switzerland EOC Bellinzona Switzerland

Sharett Institute of Oncology Department Hadassah University Hospital and Faculty of Medicine Hebrew University Jerusalem Israel

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

A retrospective single-center pilot study of the genetic background of the transplanted kidney

PloS one. 2025 ; 20 (1) : e0316192. [epub] 20250108

PLoS One
ISSN 1932-6203
Zdroj

Primary retroperitoneal nodal endometrioid carcinoma associated with Lynch syndrome: A case report

Frontiers in oncology. 2023 ; 13 () : 1092044. [epub] 20230221

Front Oncol
ISSN 2234-943X
Zdroj

Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic

Cancers. 2023 Feb 08 ; 15 (4) : . [epub] 20230208

Cancers (Basel)
ISSN 2072-6694
Zdroj

Najít záznam

v BMČ

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

Najít záznam

Citační ukazatele

Možnosti archivace